Company Information
Industry 制造业
Company Introduction 宁波索宝蛋白科技股份有限公司,2003年10月于宁波保税区注册成立,是一家全球领先的专业型植物蛋白生产商,致力于将植物蛋白天然的营养价值引入到食品和饮料、营养保健品和膳食补充剂市场。索宝蛋白聚焦大豆蛋白产业,融合了以色列索宝30多年全球领先的生产技术、研发能力和万得福20多年的行业积累和持续创新能力,具有从大豆采购、低温浸出和大豆分离蛋白、非功能性浓缩蛋白、功能性浓缩蛋白、组织化蛋白(组织蛋白、拉丝蛋白)等全系列产品的生产线,可以满足不同客户的订制化需求,为客户创造价值。索宝蛋白顺应人们对美好生活、健康餐饮的追求,打造出了索宝、万得福、绿色家园、康太、索康、索太、索乐等一系列知名品牌,以良好的品牌美誉度和知名度,成为大豆蛋白行业的主要生产者之一。公司坚持以“丰富蛋白营养,增强生命活力”为使命,以“成为全球领先的蛋白开发与应用专家”为愿景,以建设“精致化、国际化、现代化、规范化、创新型“四化一型为企业为目标,围绕客户需求创造价值,走高质量发展、变革创新发展、顺势发展之路,弘扬工匠精神,建立全球视野,树立时变理念,坚持规范发展,以创新为动力,打造成长性企业。
Main Business 大豆蛋白系列产品的研发、生产和销售。
Legal Representative 刘季善
Top Executives
董事长:刘季善
董事:马正瑜,徐广成,戴永恒,房吉国,张开勇
独立董事:宿献荣,韩跃,耿林
Top 5 Shareholder
Shareholder name Nature Holding Date
山东万得福实业集团有限公司限售股43.22%30/09/2024
济南财金复星惟实股权投资基金合伙企业(有限合伙)限售股7.04%30/09/2024
上海复星创富投资管理股份有限公司-宁波梅山保税港区复星惟盈股权投资基金合伙企业(有限合伙)限售股7.04%30/09/2024
邦吉(上海)管理有限公司限售股3.75%30/09/2024
宁波合信投资合伙企业(有限合伙)限售股3.32%30/09/2024
Company Secretary 房吉国
Solicitors 北京市康达律师事务所
Auditors 大华会计师事务所(特殊普通合伙)
Tel No 0574-86806690
Fax No 0574-86806660
Website www.solbar.com
Email stock@solbar.com
Company Address
Register: 浙江省宁波保税区兴业大道12号
Office: 浙江省宁波保税区兴业大道12号
Listing Date 15/12/2023
Shares Capital
Shares Capital: 191,459,105
Total A Share: 191,459,105
Listed A Share: 47,864,800
Non-tradable A Share: 143,594,305
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.050
DPS(RMB)* ¥ 0.500
NBV Per Share(RMB)* ¥ 9.870
Market Capitalization(RMB) 0.845B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.